Inside Sales Representative II
Thermo Fisher Scientific- Full Time
- Mid-level (3 to 4 years)
Employment Type: Full-time
Asimov is dedicated to advancing humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We are developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.
We are hiring a Business Development Associate to join our fast-growing Commercial team. This role is ideal for someone eager to develop their commercial skills and business acumen, offering high impact for an early- to mid-career professional. You will support strategic territory growth, learn from experienced colleagues, and contribute meaningfully to expanding Asimov’s presence across the biopharma ecosystem.
Location: Mid-Atlantic or Southwest U.S. (depending on skillset and team fit)
Asimov is fueled by a vision to transform biological engineering into a fully-fledged engineering discipline. Should you join our team, you will grow with a constantly evolving organization and push the frontiers of synthetic biology. Company culture is key to Asimov, and ours is a culture of recombination; we believe that our mission can only be achieved by bringing together a diverse team with a mixture of backgrounds and perspectives.
Synthetic biology solutions for biopharmaceuticals
Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.